Vijay Kamath
Vascular Surgery · Browns Mills, NJNPI 1467616995
Payments from drug & device makers
Across 22 payments — averaging $107.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$808
- Abbott$456
- W. L. Gore & Associates, Inc.$364
- Boston Scientific$317
- Endologix LLC$267
- Silk Road Medical, Inc.$125
- plus $37 from 2 others
What the payments were for
- Speaking & faculty fees$1717%
- Food & beverage$2,20393%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 9 | $808 |
| Abbott | 3 | $456 |
| W. L. Gore & Associates, Inc. | 3 | $364 |
| Boston Scientific | 2 | $317 |
| Endologix LLC | 2 | $267 |
| Silk Road Medical, Inc. | 1 | $125 |
| AbbVie | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$447
- ESPRIT$285
- Alto Abdominal Stent Graft System$267
- GENERAL BALLOONS$185
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$182
- Perclose ProGlide suture mediated closure system$171
- GORE TAG Thoracic Branch Endoprosthesis$160
- GENERAL - THERAPIES$132
- ENROUTE Transcarotid Neuroprotection System$125
- ENROUTE Transcarotid Stent$125
How this compares
$2,373 in reported general payments places this provider in the 25th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $21,380 |
| Cilostazol | 61 | $2,436 |
| ClopidogrelClopidogrel Bisulfate | 58 | $1,036 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Browns Mills
- David O'ConnorHackensack$894K
- Steven EliasEnglewood$708K
- Michael WildermanHackensack$386K
- Joseph LombardiPomona$321K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Saum RahimiNew Brunswick$101K
- Laurel HastingsCamden$98K
- Danielle PinedaPomona$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.